Diabetes and COVID-19 Pandemic: A Potential Mechanisms: A Review
Keywords:Diabetes mellitus, Coronavirus disease, Severe acute respiratory syndrome-coronavirus-2, Metformin, Dipeptidyl peptidase 4 inhibitors.
Diabetes is the greatest public condition among patients with coronavirus disease and has been found to
affect prognosis worldwide. It is revealed that hyperglycemia is one of the elements that elevates the risk of
consequences in these persons. This study designed to analysis the overall features of the novel coronavirus
and provide an understanding of the coronavirus disease in diabetic patients, and its treatment.
These patients are usually treated with various medications and this review clarify the role of metformin
and dipeptidyl peptidase 4 inhibitors as helpful factors in these patients. Recommendations are made on
the probable pathophysiological mechanisms of the association between coronavirus and diabetes, and its
management. Additional study about this association and its clinical managing is necessary
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Re use and mixing of content policy- We follow Creative Commons Licence Policy. We follow CC BY. Please refer below for all details
This license lets others distribute, remix, adapt, and build upon our work, even commercially, as long as they credit us for the original creation.
- The journal allows readers to read, download, copy, distribute, print, search, or link to the full texts of its articles and allow readers to use them for any other lawful purpose.
- The journal allows the author(s) to hold the copyright without restrictions.
- The journal allows the author(s) to retain publishing rights without restrictions